New research indicates that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end conventional lifestyle programs.
Published data in a major health publication demonstrates that while overweight individuals often shed substantial amounts of their body weight while on the medication, the weight comes back at an estimated rate of nearly a kilo each month after stopping.
"Users using such drugs should be aware of the potential of fast weight regain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
Such speed of recovery implies a reversion to original weight within about one and a half years.
Analyzing Treatments
The research, which examined dozens of trials involving thousands of patients, compared the outcomes of these new drugs with older methods.
Scientists point out that people who lose weight through dieting generally have a less rapid weight regain—around 100 grams monthly—after stopping.
Explaining the Quick Regain
Doctors propose the mode of action of the injections explains the heightened rebound.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone concentrations far above than normal might result in the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making binge eating far more likely."
A Lifelong Disease?
The NHS advise the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
A number of clinicians contend that, due to the likelihood of relapse, the treatment might need to be long-term.
This view is supported by pharmaceutical companies, who state that the results "emphasize the persistent nature of excess weight," comparing it to managing conditions like hypertension.
Patient Experiences
People who have come off the jabs describe a intense return of cravings.
"I experienced a trigger activating and you're instantly starving," described a patient.
This difficulty is worsened if users have not established sustainable dietary or behavioural changes during treatment.
Widespread Adoption
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand being substantial.
- Adoption is greater among women than males.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while the jabs are effective agents for shedding pounds, they are not a standalone fix and maintained weight loss likely depends on integrated behavioural support.
